Pharvaris N.V. (PHVS) stock
PHVSNasdaqPharmaceutical PreparationsFiscal year ends December 31
$33.36−0.47 (-1.39%)
Close on Nov 13, 2026Market cap $2.18BP/E –Yield –
Pharvaris operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
For fiscal 2025 it was -€137.07M. The highest annual figure on record is -€3.92M in fiscal 2018.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -€137.07M | – |
| FY2024 | Dec 31, 2024 | -€120.13M | – |
| FY2023 | Dec 31, 2023 | -€93.05M | – |
| FY2022 | Dec 31, 2022 | -€67.16M | – |
| FY2021 | Dec 31, 2021 | -€44.60M | – |
| FY2020 | Dec 31, 2020 | -€21.50M | – |
| FY2019 | Dec 31, 2019 | -€6.68M | – |
| FY2018 | Dec 31, 2018 | -€3.92M | – |
See a number that looks wrong?